Gilead Sciences | Capitalisation Boursière



Market Capitalization Changement Date
AbbVie USD 370.64B 56.62B 2025-03
Agios Pharmaceuticals USD 1.7B 178M 2025-03
ALKERMES USD 5.44B 790M 2025-03
Alnylam Pharmaceuticals USD 41.19B 6.06B 2025-07
Amgen USD 167.51B 27.54B 2025-03
Biogen USD 20.03B 2.25B 2025-03
BioMarin Pharmaceutical USD 13.56B 1.02B 2025-03
Bristol-Myers Squibb USD 124.1B 9.39B 2025-03
Eli Lilly USD 741.66B 8.79B 2025-03
Gilead Sciences USD 139.68B 24.59B 2025-03
GlaxoSmithKline GBP 60.35B 4.54B 2025-03
Glaxosmithkline USD 69.83B 14.22B 2024-12
Incyte USD 11.72B 1.59B 2025-03
J&J USD 396.43B 29.72B 2025-07
Merck USD 225.87B 25.78B 2025-03
Moderna USD 10.96B 5.04B 2025-03
Novartis CHF 188.82B 67.36B 2025-07
Pfizer USD 143.72B 6.63B 2025-03
PTC Therapeutics USD 4.02B 511M 2025-03
Regeneron Pharmaceuticals USD 58.9B 10.44B 2025-07
Sanofi EUR 125.84B 7.44B 2025-03
Sarepta Therapeutics USD 6.19B 5.59B 2025-03
United Therapeutics USD 13.89B 1.86B 2025-03


Gilead Sciences Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.